Biocon Biologics refinances $ 1.1 bn long-term debt through USD bonds and new syndicated facility EP News Bureau Oct 3, 2024 The Bonds are expected to be rated BB by both S&P and Fitch and will be listed on the Singapore Stock Exchange
India to become hub for COVID-19 antiviral generic drugs: Fitch Press Trust of India Jan 10, 2022 Increased access to Molnupiravir will keep hospitalisations and deaths in India to a manageable level as Omicron infections rise,…
